About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Germline Genetic Testing of the TP53 Gene | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT07419893

Germline Genetic Testing of the TP53 Gene

This is a retrospective, observational, single-center study designed as a cohort analysis. The study population will include consecutive patients referred for genetic counseling and TP53 germline gene...

Lead sponsor: European Institute of Oncology•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Mariarosaria Calvello, MD

CONTACT

+39 0294372651 mariarosaria.calvello@ieo.it

Sponsors

Lead Sponsor

European Institute of Oncology

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Have undergone at least one genetic counseling session at the Division of Cancer Prevention and Genetics of the IEO;
•Have undergone germline TP53 genetic testing, regardless of the referral criteria for counseling and/or testing or the approach used;
•Have provided written informed consent for participation in scientific research.

Exclusion Criteria

•Absence of signed informed consent for participation in scientific research.

Related studies

RECRUITINGPhase 2

Oral-ATO for TP53-mutated Myeloid Malignancies

NCT06778187 · Acute Myeloid Leukemia, Myelodysplastic Neoplasm, and more

Not Yet RecruitingNA

A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma

NCT07535840 · HCC - Hepatocellular Carcinoma, TP53 Gene Mutation, and more

Not Yet Recruiting

Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma

NCT06521684 · Endometrial Neoplasms, TP53 Gene Mutation, and more

Patogenic Mutation in 5 Genes

NCT04976439 · Colorectal Cancer, APC Gene Mutation, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 19, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment1,940

Start dateJan 2026

Last updatedFeb 19, 2026

Condition

TP53 Gene Mutation Multi-Gene Transcriptional Profiling TP53 Gene Germline Mutation Carrier

Locations shown

Istituto Europeo di Oncologia

Milan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 19, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions